Amylyx Pharmaceuticals, Inc. AMLX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s net income?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported net income of -$41.28M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s net income changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s net income decreased by 15.0% year-over-year, from -$35.91M to -$41.28M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s net income?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s net income has grown at a 13.3% compound annual growth rate (CAGR), from -$87.93M to -$144.74M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.